Literature DB >> 33141155

Prognostic Value of the post-operative Red Blood Cell Distribution Width in rectal cancer patients with neoadjuvant chemoradiation followed surgery.

Yingkun Ren1, Zhiling Wang2, Jianguo Xie1, Peijun Wang1.   

Abstract

Purposes Several studies have reported that elevated red  cell distribution width (RDW) is related to poor prognosis in several cancers; however, the prognostic significance of perioperative RDW in rectal cancer patients which received neoadjuvant chemoradiation therapy (NACRT) is unclear. Methods A total of 120 rectal cancer patients who received NACRT followed surgery were retrospectively reviewed from Affiliated Cancer Hospital of Zhengzhou University between 2013 to 2015. Data for peripheral blood tests prior to the initiation of NACRT,before surgery and first chemotherapy after surgery were collected,respectively. The optimal cutoff values of RDW was determined by ROC analysis, respectively. The relationship between RDW and the prognosis of patients was evaluated by, respectively. Results The post-operative RDWHigh (≥15.55) patients had significantly worse five-year overall survival (OS, P=0.001) and disease-free survival (DFS, P=0.001) than the post-operative RDWLow (<15.55) patients, respectively. Whereas high pre-operative RDW  (≥16.45) was the only marker correlated with worse DFS (P=0.005) than the pre-operative RDWLow (<16.45)patients, no relationship was found between pre-RDW and prognosis(OS, P=0.069; DFS, P=0.133). Multivariate analysis showed post-operative RDW had better predictive value than pre-RDW and pre-operative RDW. Conclusion Post-operative RDW might be a useful prognostic indicator in rectal cancer patients received neoadjuvant chemoradiation. Copyright 2020 The Author(s).

Entities:  

Keywords:  neoadjuvant chemotherapy; prognosis; rectal cancer; red-cell distribution width

Year:  2020        PMID: 33141155      PMCID: PMC7753744          DOI: 10.1042/BSR20201822

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  26 in total

1.  NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Authors:  Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908

2.  Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients - the Tromsø Study.

Authors:  Trygve S Ellingsen; Jostein Lappegård; Tove Skjelbakken; Sigrid K Braekkan; John-Bjarne Hansen
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

Review 3.  Red cell distribution width and cancer.

Authors:  Martina Montagnana; Elisa Danese
Journal:  Ann Transl Med       Date:  2016-10

4.  Clinical significance of an increased red blood cell distribution width in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.

Authors:  Shozo Ide; Yuji Toiyama; Yoshinaga Okugawa; Yusuke Omura; Takahito Kitajima; Hiroyuki Fujikawa; Junichiro Hiro; Masaki Ohi; Masato Kusunoki
Journal:  Surg Today       Date:  2019-12-20       Impact factor: 2.549

5.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

Review 6.  Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer.

Authors:  Wei Chua; Patricia S Kho; Melissa M Moore; Kellie A Charles; Stephen J Clarke
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-16       Impact factor: 6.312

7.  Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer.

Authors:  Aijie Li; Kewen He; Dong Guo; Chao Liu; Duoying Wang; Xiangkui Mu; Jinming Yu
Journal:  Future Oncol       Date:  2019-08-02       Impact factor: 3.404

8.  The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.

Authors:  Zhiling Wang; Jie Wang; Peijun Wang
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.752

9.  Combining Red Blood Cell Distribution Width (RDW-CV) and CEA Predict Poor Prognosis for Survival Outcomes in Colorectal Cancer.

Authors:  Yalun Li; Chengzhong Xing; Minjie Wei; Huizhe Wu; Xiaoyun Hu; Shanqiong Li; Guangwei Sun; Guangzhe Zhang; Bo Wu; Fangxiao Zhang; Zhuang Li
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

10.  Relationship between red cell distribution width and prognosis of patients with osteosarcoma.

Authors:  Jian Zheng; Xiaopin Yuan; Weichun Guo
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

View more
  1 in total

1.  Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients.

Authors:  Lei Fu; Qian Li; Qingxia Fan
Journal:  J Gastrointest Oncol       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.